LLY241018C892500
- 36.23
- +12.68+53.84%
Eli Lilly and Co Newsroom
Express News | Eli Lilly and Co - Submits Marketing Authorization Applications for Mirikizumab Globally
Express News | Eli Lilly and Co - Mirikizumab Safety Profile in Crohn's Disease Consistent With Ulcerative Colitis
Express News | Lilly Reports One-Year Histologic Outcomes in Phase 3 Study of Mirikizumab Compared to Ustekinumab for Crohn's Disease
Express News | Eli Lilly : Guggenheim Cuts Target Price to $1,024 From $1,030
Lilly Reports One-year Histologic Outcomes in Phase 3 Study of Mirikizumab Compared to Ustekinumab for Crohn's Disease
Express News | UK's Department of Health and Social Care: Lilly Confirms Plans to Launch First European 'lilly Gateway Labs' Innovation Accelerator
Express News | UK's Department of Health and Social Care: £279 Mln From 'eli Lilly and Company' as Part of Collaboration
Express News | UK's Department of Health and Social Care: Memorandum of Understanding Signed Between Hmg & Eli Lilly to Back UK Life Sciences
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Eli Lilly and Co (LLY.US) CEO: Its Alzheimer's drugs can play a "preventive" role.
Eli Lilly and Co's CEO told the United Kingdom Health Minister that their method of treating Alzheimer's disease can 'prevent' the disease.
Eli Lilly CEO Told UK Health Secretary Its Alzheimer's Treatment Could "Prevent" Disease: FT
Weight Loss Drugs Have One Big Issue; These Companies Want to Fix It
Boasting A 54% Return On Equity, Is Eli Lilly and Company (NYSE:LLY) A Top Quality Stock?
Eli Lilly and Company (LLY): Among the Most Promising Growth Stocks According to Hedge Funds
Streetwise: Snack Slump Hits Big Food. Blame Prices, Not Obesity Meds. -- Barron's
US stocks closed: on the two-year anniversary of this bull market, the S&P and Dow hit new highs, while Chinese stocks collectively strengthened.
①The s&p 500 index welcomes the second anniversary of the bull market, historically breaking through the 5800-point integer mark for the first time on Friday; ②The nasdaq china golden dragon index has closed higher for two consecutive days; ③Tesla tumbled by 8%, while uber technologies and Lyft strengthened; ④Boeing announced a 10% workforce reduction.
Express News | US FDA Seeks to Reconsider Decision Preventing Drug Compounders From Selling Versions of Lilly's Weight Loss, Diabetes Drugs
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Eli Lilly Expects Zepbound Approval in Japan by Mid-2025, Eyes Weight-Loss Market